scholarly journals How to select Tyrosine Kinase Inhibitor for the patients with newly diagnosed Chronic Myeloid Leukemia?

2018 ◽  
Vol 4 (1) ◽  
Author(s):  
Nakaya A ◽  
Fujita S ◽  
Satake A ◽  
Nakanishiq T ◽  
Azuma Y ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Newly Diagnosed

scholarly journals Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities

Blood ◽  
2013 ◽  
Vol 121 (24) ◽  
pp. 4867-4874 ◽  
Author(s):  
Preetesh Jain ◽  
Hagop Kantarjian ◽  
Aziz Nazha ◽  
Susan O’Brien ◽  
Elias Jabbour ◽  
...  
Keyword(s):  
Multivariate Analysis ◽  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Treatment Modality ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Early Response ◽  
Newly Diagnosed ◽  
Key Points

Key Points This analysis demonstrates the universality of the early response in CML, regardless of the treatment modality used. Factors correlating with poor cytogenetic responses at 3-mo assessment in a multivariate analysis across all 4 TKIs.

Sign in / Sign up

Export Citation Format

Share Document